Results 231 to 240 of about 14,404,861 (385)

Department of General Medicine [PDF]

, 2013
中垣内 浩子, 傍島 光男, 北 啓一朗, 小浦 友行, 山城 清二, 川渕 奈三栄, 黒岩 麻衣子   +6 more
core   +1 more source

Text-Book of Comparative General Pathology for Practitioners and Students of Veterinary Medicine

, 1907

openalex   +3 more sources

Qualitative process evaluation of a new short-hospital-stay model with a general medicine focus in Germany (STATAMED): Study protocol. [PDF]

PLoS One
van Baal K, Poeck J, Lemmen CM, Böhne W, Jahn J, Wild EM, Schneider N.   +6 more
europepmc   +1 more source

SYHA1813, A VEGFR and CSF1R Inhibitor, in Patients With Recurrent High‐Grade Gliomas: A Multicenter, Open‐Label Phase I Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Recurrent high‐grade gliomas have a poor prognosis and limited therapeutic options. This study aimed to evaluate the safety and efficacy of SYHA1813, a dual inhibitor of VEGFR and CSF1R, in patients with recurrent high‐grade gliomas.
Zhuang Kang, Shenglan Li, Liang Wang, Qianxue Chen, Weiguo Hu, Ting Lei, Ying Mao, Jing Zhang, Xiaojun Xiang, Qiming Wang, Zhengwen He, Tao Sun, Yulei Wang, Mengqian Huang, Rong Zhang, Feng Chen, Wenbin Li   +16 more
wiley   +1 more source

Perceptions, attitudes, and barriers to research engagement among general medicine undergraduates in a tertiary hospital in Guangdong, China. [PDF]

BMC Med Educ
Hou Y, Hu L, Qiu S, Yan Z, Zhou M, Zheng F, Li Z, Ke X, Huang Y.   +8 more
europepmc   +1 more source

Discussion on Radiotherapy in Medicine and Surgery from the General Practitioner's Point of View [PDF]

, 1955

openalex   +1 more source

Functional Connectivity Associations With Markers of Disease Progression in GRN Pathogenic Variant Carriers

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autosomal dominant progranulin (GRN) pathogenic variants are a genetic cause of frontotemporal lobar degeneration. Though clinical trials for GRN‐related therapies are underway, there is an unmet need for biomarkers that can predict symptom onset and track disease progression.
Taru M. Flagan, Stephanie A. Chu, Suvi Häkkinen, Liwen Zhang, David McFall, Jonathan D. Rohrer, Jesse A. Brown, Alex J. Lee, Kristen Fernhoff, Lorenzo Pasquini, Katherine P. Rankin, Maria Luisa Mandelli, Maria Luisa Gorno‐Tempini, Jennifer S. Yokoyama, Virginia E. Sturm, Brian Appleby, Bradford C. Dickerson, Kimiko Domoto‐Reilly, Tatiana Foroud, Daniel H. Geschwind, Nupur Ghoshal, Neill R. Graff‐Radford, Ging‐Yuek Robin Hsiung, Eric J. Huang, Edward Huey, Kejal Kantarci, Irene Litvan, Ian R. Mackenzie, Mario F. Mendez, Chiadi U. Onyike, Leonard Petrucelli, Eliana Marisa Ramos, Erik D. Roberson, Julio C. Rojas, Maria Carmela Tartaglia, Arthur W. Toga, Sandra Weintraub, Leah K. Forsberg, Hilary W. Heuer, Brad F. Boeve, Adam L. Boxer, Howard J. Rosen, Bruce L. Miller, Fermin Moreno, William W. Seeley, Suzee E. Lee, on behalf of the ALLFTD Consortium   +46 more
wiley   +1 more source

Department of General Medicine [PDF]

, 2009
北 啓一朗, 室林 治, 山城 清二
core   +1 more source

Practice Recommendations for Genetic Testing of Ataxias

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Over the past decade, significant advances in genetic testing for ataxia have improved diagnostic accuracy, informed clinical trial eligibility, guided treatment decisions, and enabled cascade testing of at‐risk relatives. While guidance exists for other neurogenetic conditions, there are no standardized guidelines on genetic ...
Sharan R. Srinivasan, Amy D. Mook, Michelle Rochman, Jin Yun Helen Chen, Weiyi Mu, George R. Wilmot, Liana S. Rosenthal, Wendy R. Uhlmann   +7 more
wiley   +1 more source

Phenotyping to predict 12-month health outcomes of older general medicine patients. [PDF]

Aging Clin Exp Res
Woodman RJ, Bryant K, Sorich MJ, Thompson CH, Russell P, Pilotto A, Mangoni AA.   +6 more
europepmc   +1 more source